{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,27]],"date-time":"2025-04-27T13:22:36Z","timestamp":1745760156939},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00347-013-3001-0","type":"journal-article","created":{"date-parts":[[2014,2,7]],"date-time":"2014-02-07T08:32:33Z","timestamp":1391761953000},"page":"173-180","source":"Crossref","is-referenced-by-count":21,"title":["Mineralokortikoidrezeptorantagonisten als Therapieoption bei akuter und chronischer Chorioretinopathia centralis serosa"],"prefix":"10.1007","volume":"111","author":[{"given":"M.","family":"Maier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Stumpfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Feucht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Strobl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Rath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.P.","family":"Lohmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,8]]},"reference":[{"key":"3001_CR1","first-page":"1","volume":"2","author":"Alomran","year":"2010","unstructured":"Alomran MS (2010) Intravitreal bevacizumab for the treatment of central serous chorioretinopathy. Ophthalmic Surg Lasers Imaging 2:1\u20133","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"3001_CR2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/02713680903428306","volume":"35","author":"Artunay","year":"2010","unstructured":"Artunay O, Yuzbasioglu E, Rasier R et al (2010) Intravitreal bevacizumab in treatment of idiopathic persistent central serous chorioretinopathy: a prospective, controlled clinical study. Curr Eye Res 35:91\u201398","journal-title":"Curr Eye Res"},{"key":"3001_CR3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00347-010-2154-3","volume":"107","author":"Baraki","year":"2010","unstructured":"Baraki H, Feltgen N, Roider J et al (2010) Central serous chorioretinopathy (CSC). Ophthalmologe 107:479\u2013492","journal-title":"Ophthalmologe"},{"key":"3001_CR4","unstructured":"Behar-Cohen F (2012) New insight in the physiopathology of CSCR: therapeutic application, Retina subspecialty day, AAO"},{"key":"3001_CR5","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1097\/IAE.0b013e318297a07a","volume":"33","author":"Bousquet","year":"2013","unstructured":"Bousquet E, Beydoun T, Zhao M et al (2013) Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy. A pilot study. Retina 33(10):2096\u20132102","journal-title":"Retina"},{"key":"3001_CR6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0039-6257(02)00338-7","volume":"47","author":"Bouzas","year":"2002","unstructured":"Bouzas EA, Karadimas P, Pournaras CJ (2002) Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 47:431\u2013448","journal-title":"Surv Ophthalmol"},{"key":"3001_CR7","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00347-006-1416-6","volume":"103","author":"Brinkmann","year":"2006","unstructured":"Brinkmann R, Schule G, Neumann J et al (2006) Selektive Retinatherapie: Methodik, Technik und Online-Dosimetrie. Ophthalmologe 103:839\u2013849","journal-title":"Ophthalmologe"},{"key":"3001_CR8","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.ophtha.2008.04.014","volume":"115","author":"Chan","year":"2008","unstructured":"Chan WM et al (2008) Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. Ophthalmology 115:1756\u20131765","journal-title":"Ophthalmology"},{"key":"3001_CR9","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1136\/bjo.87.12.1453","volume":"87","author":"Chan","year":"2003","unstructured":"Chan WM et al (2003) Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 87:1453\u20131458","journal-title":"Br J Ophthalmol"},{"key":"3001_CR10","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.ophtha.2008.08.026","volume":"115","author":"Chen","year":"2008","unstructured":"Chen SN et al (2008) Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage. Ophthalmology 115:2229\u20132234","journal-title":"Ophthalmology"},{"key":"3001_CR11","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1007\/s00417-006-0368-5","volume":"244","author":"Elsner","year":"2006","unstructured":"Elsner H et al (2006) Selective retina therapy in patients with central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 244:1638\u20131645","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3001_CR12","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/IAE.0b013e3181f04a35","volume":"31","author":"Forooghian","year":"2011","unstructured":"Forooghian F, Meleth AD, Cukras C et al (2011) Finasteride for chronic central serous chorioretinopathy. Retina 31(4):766\u2013771","journal-title":"Retina"},{"key":"3001_CR13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0420.2005.00442.x","volume":"83","author":"Framme","year":"2005","unstructured":"Framme C et al (2005) Fundus autofluorescence in acute and chronic-recurrent central serous chorioretinopathy. Acta Ophthalmol Scand 83:161\u2013167","journal-title":"Acta Ophthalmol Scand"},{"key":"3001_CR14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF02720786","volume":"12","author":"Graefe","year":"1866","unstructured":"Graefe A (1866) \u00dcber die zentrale rezidivierende Retinitis. Graefes Arch Ophthalmol 12:211\u2013215","journal-title":"Graefes Arch Ophthalmol"},{"key":"3001_CR15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10792-009-9302-2","volume":"30","author":"Gupta","year":"2010","unstructured":"Gupta P et al (2010) Morphological changes in the retinal pigment epithelium on spectral-domain OCT in the unaffected eyes with idiopathic central serous chorioretinopathy. Int Ophthalmol 30:175\u2013181","journal-title":"Int Ophthalmol"},{"key":"3001_CR16","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/IAE.0b013e3181be0a83","volume":"29","author":"Imamura","year":"2009","unstructured":"Imamura Y, Fujuwara T, Margolis R, Spaide RF (2009) Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 29:1469\u20131473","journal-title":"Retina"},{"key":"3001_CR17","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/bjo.87.6.709","volume":"87","author":"Kitaya","year":"2003","unstructured":"Kitaya N, Nagaoka T, Hikichi T et al (2003) Features of abnormal choroidal circulation in central serous chorioretinopathy. Br J Ophthalmol 87:709\u2013712","journal-title":"Br J Ophthalmol"},{"key":"3001_CR18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ophtha.2007.02.032","volume":"115","author":"Kitzmann","year":"2008","unstructured":"Kitzmann AS, Pulido JS, Diehl NN et al (2008) The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980\u20132002. Ophthalmology 115:169\u2013173","journal-title":"Ophthalmology"},{"key":"3001_CR19","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1007\/s00347-006-1415-7","volume":"103","author":"Klatt","year":"2006","unstructured":"Klatt C et al (2006) Selective retina therapy in central serous chorioretinopathy with detachment of the pigmentary epithelium. Ophthalmologe 103:850\u2013855","journal-title":"Ophthalmologe"},{"key":"3001_CR20","doi-asserted-by":"crossref","unstructured":"Koss MJ, Beger I, Koch FH (2012) Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy. Eye (Lond) 26(2):307\u2013314","DOI":"10.1038\/eye.2011.282"},{"key":"3001_CR21","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00347-011-2419-5","volume":"108","author":"Maier","year":"2011","unstructured":"Maier M, Valet V, Feucht N, Lohmann CP (2011) Therapy options for chronic central serous chorioretinopathy. Photodynamic therapy combined with bevacizumab \u2013 a case series. Ophthalmologe 108(11):1027\u20131031","journal-title":"Ophthalmologe"},{"key":"3001_CR22","doi-asserted-by":"crossref","unstructured":"Maier M, Strobl P, Feucht N et al (2013) Spironolacton als Therapieoption bei akuter und chronischer Chorioretinopathia centralis serosa (CCS): Eine Fallserie, Abstract DOG 2013","DOI":"10.1007\/s00347-013-3001-0"},{"key":"3001_CR23","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.ophtha.2010.01.023","volume":"117","author":"Maruko","year":"2010","unstructured":"Maruko I, Iida T, Sugano Y et al (2010) Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology 117:1792\u20131799","journal-title":"Ophthalmology"},{"key":"3001_CR24","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/IAE.0b013e318050ca69","volume":"27","author":"Meyerle","year":"2007","unstructured":"Meyerle CB, Freund KB, Bhatnagar P et al (2007) Ketoconazole in the treatment of chronic idiopathic central serous chorioretinopathy. Retina 27:943\u2013946","journal-title":"Retina"},{"key":"3001_CR25","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0161-6420(02)01157-0","volume":"109","author":"Pikkel","year":"2002","unstructured":"Pikkel J, Beiran I, Ophir A et al (2002) Acetazolamide for central serous retinopathy. Ophthalmology 109:1723\u20131725","journal-title":"Ophthalmology"},{"key":"3001_CR26","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/112067210901900415","volume":"19","author":"Schaal","year":"2009","unstructured":"Schaal KB, Hoeh AE, Scheuerle A et al (2009) Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy. Eur J Ophthalmol 19:613\u2013617","journal-title":"Eur J Ophthalmol"},{"key":"3001_CR27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-2004-819873","volume":"54","author":"Spahn","year":"2004","unstructured":"Spahn C, Wiek J, Burger T (2004) Operationalized psychodynamic diagnostics (OPD) in patients with central serous chorioretinopathy. Psychother Psychosom Med Psychol 54:52\u201357","journal-title":"Psychother Psychosom Med Psychol"},{"key":"3001_CR28","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/bjo.87.6.704","volume":"87","author":"Spahn","year":"2003","unstructured":"Spahn C, Wiek J, Burger T et al (2003) Psychosomatic aspects in patients with central serous chorioretinopathy. Br J Ophthalmol 87:704\u2013708","journal-title":"Br J Ophthalmol"},{"key":"3001_CR29","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0161-6420(96)30386-2","volume":"103","author":"Spaide","year":"1996","unstructured":"Spaide RF, Campeas L, Haas A et al (1996) Central serous chorioretinopathy in younger and older adults. Ophthalmology 103:2070\u20132080","journal-title":"Ophthalmology"},{"key":"3001_CR30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00006982-199616030-00004","volume":"16","author":"Spaide","year":"1996","unstructured":"Spaide RF, Hall L, Haas A et al (1996) Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 16:203\u2013213","journal-title":"Retina"},{"key":"3001_CR31","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1055\/s-2008-1027271","volume":"225","author":"Stoffelns","year":"2008","unstructured":"Stoffelns BM, Kramann C, Schoepfer K (2008) Central serous chorioretinopathy (CSC) and corticosteroids. Klin Monatsbl Augenheilkd 225:370\u2013375","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"3001_CR32","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00347-012-2588-x","volume":"109","author":"Valet","year":"2012","unstructured":"Valet V, Lohmann CP, Maier M (2012) Spectral domain OCT in central serous chorioretinopathy: description of retinal changes (Spectralis OCT bei Chorioretinopathia centralis serosa). Ophthalmologe 109(9):879\u2013887","journal-title":"Ophthalmologe"},{"key":"3001_CR33","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-0420.2007.00889.x","volume":"86","author":"Wang","year":"2008","unstructured":"Wang M, Munch IC, Hasler PW et al (2008) Central serous chorioretinopathy. Acta Ophthalmol 86:126\u2013145","journal-title":"Acta Ophthalmol"},{"key":"3001_CR34","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00006982-200306000-00002","volume":"23","author":"Yannuzzi","year":"2003","unstructured":"Yannuzzi LA, Slakter JS, Gross NE et al (2003) Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 23:288\u2013298","journal-title":"Retina"},{"key":"3001_CR35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ajo.2009.11.017","volume":"149","author":"Yannuzzi","year":"2010","unstructured":"Yannuzzi LA (2010) Central serous chorioretinopathy: a personal perspective. Am J Ophthalmol 149:361\u2013363","journal-title":"Am J Ophthalmol"},{"key":"3001_CR36","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI61427","volume":"122","author":"Zhao","year":"2012","unstructured":"Zhao M, C\u00e9l\u00e9rier I, Bousquet E et al (2012) Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. J Clin Invest 122(7):2672\u20132679","journal-title":"J Clin Invest"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-013-3001-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-013-3001-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-013-3001-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T12:21:04Z","timestamp":1565180464000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-013-3001-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["3001"],"URL":"https:\/\/doi.org\/10.1007\/s00347-013-3001-0","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}